Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                International Activities

International Activities

                        Regulatory Harmonization and Convergence
          Foreign Regulators – Information and Training Resources
          Foreign Regulator Information Exchanges
          International Engagements to Respond to Covid-19 Pandemic
          Quick Guide to Web Resources
          Foreign Regulatory Seminar (Web-Based): CBERs Regulation of Biologics


                        WHO Engagements Home
          Vaccines, Blood & Biologics
          International Activities
          Foreign Regulatory Seminar (Web-Based): CBERs Regulation of BiologicsInternational Activities Foreign Regulatory Seminar (Web-Based): CBERs Regulation of Biologics
  
  	
    Share
    Post
    Linkedin

    Email
    PrintIntroduction

The Center for Biologics Evaluation and Research (CBER) is pleased to provide a web-based informational program to explain CBER’s oversight of biological products in the United States.  It is intended primarily for the benefit of our foreign regulatory counterparts, however, the information may be of interest to other parties as well.

This outreach program was generated from a live program originally held in October 2009. With modest editing, staff developed this web-based production in order to more effectively reach a broader audience than was possible by offering in-person programs. The training material was updated in 2019 to stay abreast of legislative and organizational changes that occurred since the program was first developed.

Many questions regarding CBER and its oversight of the products under its jurisdiction can be answered by viewing the program. However, CBER has generated an email address that can be used to submit any specific questions that might not be addressed by the program content. Email questions or comments to: ForeignRegOutreach@fda.hhs.gov.

CBER appreciates your interest in the U.S. regulation of biologics. Thank you.

Introduction and Overview of The Center for Biologics Evaluation and Research (CBER)

An introduction to the FDA’s Center for Biologics Evaluation and Research providing an overview of its regulatory mission, relating the complexity of biologic products regulated, and discussing examples of applied scientific research conducted in support of U.S. and global public health.

Peter Marks, M.D., PhD
Director
Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Presentation Materials
	Presentation
	Printable script
	Printable script also available en Français
	Printable script also available en Espanol
	Printable script also available en Chinese

New At CBER: Regulatory and Organizational Updates

Discussion of the organizational changes within CBER, and the updated regulatory approaches from the perspective of each CBER product office, reflecting CBER’s current thinking on the regulation of biologics. This includes specific updates to the existing information contained in the foreign regulatory seminar program.
Presentation Materials
	Presentation
	Printable script
	Printable script also available en Français
	Printable script also available en Espanol
	Printable script also available en Chinese

CBER Office Presentations

Select each heading below to access the associated presentations
Presentation Materials
	Regulatory Overview
	Office of Blood Research and Review
	Office of Biostatistics and Epidemiology
	Office of Compliance and Biologics Quality
	Office of Tissues and Advanced Therapies
	Office of Vaccines Research and Review

                                                                                  Content current as of:
      09/15/2020
              
              
Regulated Product(s)
		 BiologicsInternational Activities

          
                        Regulatory Harmonization and Convergence
          Foreign Regulators – Information and Training Resources
          Foreign Regulator Information Exchanges
          International Engagements to Respond to Covid-19 Pandemic
          Quick Guide to Web Resources
          Foreign Regulatory Seminar (Web-Based): CBERs Regulation of Biologics


                        WHO Engagements
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop